US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma

Edward R.Scheffer Cliff, David A. Russler-Germain, C. Joseph Ross Daval, Aaron S. Kesselheim

Research output: Contribution to journalComment/debate

Abstract

The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.

Original languageEnglish
Pages (from-to)3901-3904
Number of pages4
JournalJournal of Clinical Oncology
Volume42
Issue number33
DOIs
StatePublished - Nov 20 2024

Fingerprint

Dive into the research topics of 'US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma'. Together they form a unique fingerprint.

Cite this